STOCK TITAN

Teligent Announces Conversion Rate Adjustment for its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes Due 2023 and its 4.75% Convertible Senior Notes Due 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Rhea-AI Summary

Teligent, Inc. (NASDAQ: TLGT) announced conversion rate adjustments for its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes and 4.75% Convertible Senior Notes, following a one-for-ten reverse stock split effective from May 28, 2020. The new conversion rates are now 138.8897 shares per $1,000 of Series B Notes and 22.4720 shares per $1,000 of 4.75% Notes. This adjustment aligns with the terms set in the indentures governing these notes and has been communicated to the noteholders and the trustee.

Loading...
Loading translation...

Positive

  • Adjustments in conversion rates enhance clarity for investors.
  • The company is proceeding with financial restructuring.

Negative

  • The reverse stock split could indicate financial distress.
  • Market perception may adversely impact stock price.

News Market Reaction – TLGT

-3.13%
1 alert
-3.13% News Effect

On the day this news was published, TLGT declined 3.13%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

BUENA, N.J., June 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today conversion rate adjustments for the Company’s 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes Due 2023 (the “Series B Notes”) and its 4.75% Convertible Senior Notes Due 2023 (the “4.75% Notes”). The conversion rate adjustments are being made pursuant to the indentures governing the Series B Notes and 4.75% Notes as a result of the Company’s previously announced one-for-ten reverse stock split. Prior to the reverse stock split, the conversion rates were 1,388.889 shares of Common Stock per $1,000 principal amount of the Series B Notes and 224.7191 shares of Common Stock per $1,000 principal amount of the 4.75% Notes. As a result of the reverse stock split, effective immediately after the open of business on May 28, 2020, the conversion rates are 138.8897 shares of Common Stock per $1,000 principal amount of the Series B Notes and 22.4720 shares of Common Stock per $1,000 principal amount of the 4.75% Notes. Notice of the conversion rate adjustments was delivered to holders of the Series B Notes and 4.75% Notes and Wilmington Trust National Association, as trustee, in accordance with the terms of the indentures governing the Series B Notes and 4.75% Notes.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. These forward-looking statements include, but are not limited to, plans, objectives, expectations and intentions, and other statements contained in this press release that are not historical facts and statements identified by words such as “plan,” “believe,” “continue,” “should” or words of similar meaning. Factors that could cause actual results to differ materially from these expectations include, but are not limited to: our inability to meet current or future regulatory requirements in connection with existing or future ANDAs; our inability to achieve profitability; our failure to obtain FDA approvals as anticipated; our inability to execute and implement our business plan and strategy; the potential lack of market acceptance of our products; our inability to protect our intellectual property rights; changes in global political, economic, business, competitive, market and regulatory factors; and our inability to successfully complete future product acquisitions. These statements are based on our current beliefs or expectations and are inherently subject to various risks and uncertainties, including those set forth under the caption “Risk Factors” in Teligent, Inc.’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other periodic reports we file with the Securities and Exchange Commission. Teligent, Inc. does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise, except as required by law.

Contact:Damian Finio
 Teligent, Inc.
 (856) 336-9117
 www.teligent.com 

FAQ

What are the new conversion rates for Teligent's Series B Senior Unsecured Convertible Notes?

The new conversion rate for the Series B Senior Unsecured Convertible Notes is 138.8897 shares per $1,000 principal amount.

What changes occurred due to Teligent's reverse stock split on May 28, 2020?

The one-for-ten reverse stock split adjusted the conversion rates for Teligent’s convertible notes.

How does the reverse stock split affect Teligent's 4.75% Convertible Senior Notes?

The conversion rate for the 4.75% Convertible Senior Notes is now 22.4720 shares per $1,000 principal amount post-split.
TLGT

NASDAQ:TLGT

TLGT Rankings

TLGT Latest News

TLGT Stock Data

92.77M
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Buena